ICOS and neoplasm: MEDI-570 is an IgG1κ mAb that attaches to the ligand-binding domain of ICOS expressed on tumor-infiltrating CD4 + T cells, therefore preventing the interaction between ICOS + T cells and plasmacytoid dendritic cells (pDCs).